Q1 FY27 results: Revenue up 13 percent, Profit after tax down 22 percent YoY
ACI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.8 pts less than Nifty Microcap 250 and 6.1 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved Q1 FY27 unaudited results on July 30, 2026. Standalone revenue rose to Rs 31,593 lakhs (up 13 percent YoY), but profit after tax fell to Rs 4,053 lakhs (down 22 percent YoY) due to higher other expenses. Consolidated revenue rose to Rs 32,720 lakhs with PAT at Rs 3,035 lakhs. EPS stood at Rs 3.28 standalone and Rs 2.48 consolidated. Auditors gave an unmodified review report. Company also invested Rs 17,000 lakhs via rights issue into wholly owned subsidiary Acume Chemicals.
Mixed quarter as topline growth failed to lift bottomline amid cost pressures. Watch margin trajectory and subsidiary investments.